(R)-α-Lipoyl-Glycyl-L-Prolyl-L-Glutamyl Dimethyl Ester Codrug as a Multifunctional Agent with Potential Neuroprotective Activities

被引:39
作者
Cacciatore, Ivana [1 ]
Baldassarre, Leonardo [1 ]
Fornasari, Erika [1 ]
Cornacchia, Catia [1 ]
Di Stefano, Antonio [1 ]
Sozio, Piera [1 ]
Cerasa, Laura Serafina [1 ]
Fontana, Antonella [1 ]
Fulle, Stefania [2 ]
Di Filippo, Ester Sara [2 ]
La Rovere, Rita Maria Laura [2 ]
Pinnen, Francesco [1 ]
机构
[1] Univ G DAnnunzio, Dipartimento Farm, I-66100 Chieti, Italy
[2] Univ G DAnnunzio, Dipartimento Neurosci & Imaging, I-66100 Chieti, Italy
关键词
(R)-alpha-lipoic acid; antioxidants; glycyl-L-prolyl-L-glutamate; neurodegenerative diseases; neurological agents; peptides; MEMBRANE-PERMEABILITY ASSAY; N-TERMINAL TRIPEPTIDE; OXIDATIVE STRESS; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; SELECTIVE INCREASE; ALZHEIMERS-DISEASE; L-DOPA; BRAIN; ANTIOXIDANTS;
D O I
10.1002/cmdc.201200320
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The (R)-alpha-lipoyl-glycyl-L-prolyl-L-glutamyl dimethyl ester codrug (LA-GPE, 1) was synthesized as a new multifunctional drug candidate with antioxidant and neuroprotective properties for the treatment of neurodegenerative diseases. Physicochemical properties, chemical and enzymatic stabilities were evaluated, along with the capacity of LA-GPE to penetrate the bloodbrain barrier (BBB) according to an in vitro parallel artificial membrane permeability assay for the BBB. We also investigated the potential effectiveness of LA-GPE against the cytotoxicity induced by 6-hydroxydopamine (6-OHDA) and H2O2 on the human neuroblastoma cell line SH-SY5Y by using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction assay. Our results show that codrug 1 is stable at both pH 1.3 and 7.4, exhibits good lipophilicity (log P=1.51) and a pH-dependent permeability profile. Furthermore, LA-GPE was demonstrated to be significantly neuroprotective and to act as an antioxidant against H2O2- and 6-OHDA-induced neurotoxicity in SH-SY5Y cells.
引用
收藏
页码:2021 / 2029
页数:9
相关论文
共 55 条
[1]   Oxidative DNA damage in the parkinsonian brain: An apparent selective increase in 8-hydroxyguanine levels in substantia nigra [J].
Alam, ZI ;
Jenner, A ;
Daniel, SE ;
Lees, AJ ;
Cairns, N ;
Marsden, CD ;
Jenner, P ;
Halliwell, B .
JOURNAL OF NEUROCHEMISTRY, 1997, 69 (03) :1196-1203
[2]   Pharmacokinetics of glycine-proline-glutamate, the N-terminal tripeptide of insulin-like growth factor-1, in rats [J].
Batchelor, DC ;
Lin, H ;
Wen, JY ;
Keven, C ;
Van Zijl, PL ;
Breier, BH ;
Gluckman, PD ;
Thomas, GB .
ANALYTICAL BIOCHEMISTRY, 2003, 323 (02) :156-163
[3]   Glutathione, iron and Parkinson's disease [J].
Bharath, S ;
Hsu, M ;
Kaur, D ;
Rajagopalan, S ;
Andersen, JK .
BIOCHEMICAL PHARMACOLOGY, 2002, 64 (5-6) :1037-1048
[4]   NNZ-2566: A Gly-Pro-Glu analogue with neuroprotective efficacy in a rat model of acute focal stroke [J].
Bickerdike, Michael J. ;
Thomas, Gregory B. ;
Batchelor, David C. ;
Sirimanne, Ernest S. ;
Leong, Wing ;
Lin, Hai ;
Sieg, Frank ;
Wen, Jingyuan ;
Brimble, Margaret A. ;
Harris, Paul W. ;
Gluckman, Peter D. .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 278 (1-2) :85-90
[5]   Synthesis and biological evaluation of a novel pyroglutamyl-modified TRH analogue [J].
Brunetti, L ;
Cacciatore, I ;
Di Stefano, A ;
Duprè, S ;
Giorgi, A ;
Luisi, G ;
Michelotto, B ;
Orlando, G ;
Pinnen, F ;
Recinella, L ;
Sozio, P ;
Spirito, A .
FARMACO, 2002, 57 (06) :479-486
[6]  
Cacciatore I., 2003, Farmaco (Lausanne), V58, P787, DOI 10.1016/S0014-827X(03)00135-6
[7]   GPE and GPE Analogues as Promising Neuroprotective Agents [J].
Cacciatore, I. ;
Cornacchia, C. ;
Baldassarre, L. ;
Fornasari, E. ;
Mollica, A. ;
Stefanucci, A. ;
Pinnen, F. .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2012, 12 (01) :13-23
[8]   Recent Advances in the Treatment of Neurodegenerative Diseases Based on GSH Delivery Systems [J].
Cacciatore, Ivana ;
Baldassarre, Leonardo ;
Fornasari, Erika ;
Mollica, Adriano ;
Pinnen, Francesco .
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2012, 2012
[9]  
Caron G, 1999, HELV CHIM ACTA, V82, P1211, DOI 10.1002/(SICI)1522-2675(19990804)82:8<1211::AID-HLCA1211>3.0.CO
[10]  
2-K